✦ LIBER ✦

Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study

✍ Scribed by Daphne Tsoi; Claire Holloway; Louise Bordeleau; Christine Brezden-Masley; Petrina Causer; Ellen Warner

Book ID: 113507280
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 103 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2010.08.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast density as indicator for the use

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

✍ Sepideh Saadatmand, Emiel J T Rutgers, Rob AEM Tollenaar, Hermien M Zonderland, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 176 KB

Adherence to a randomized controlled tri

Adherence to a randomized controlled trial of aerobic exercise in breast cancer survivors: the Yale exercise and survivorship study

✍ Rebecca N. Latka; Marty Alvarez-Reeves; Lisa Cadmus; Melinda L. Irwin 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 166 KB

The adverse implications of the transiti

The adverse implications of the transition from film to digital mammography for performing surveillance in patients with a history of breast cancer or significant risk factors for the disease

✍ Rachel L WARD; David SPEAKMAN; Michael A HENDERSON 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A phase 3 tRial comparing capecitabinE i

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

✍ José Baselga, Frederico Costa, Henry Gomez, Clifford A Hudis, Bernardo Rapoport… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 246 KB

A randomized trial of megestrol acetate

A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer: A study of the Eastern Cooperative Oncology Group (E2185)

✍ Charles D. Cobau; Katrien Declercq; Donna Neuberg; James N. Ingle; Douglass C. T 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## BACKGROUND. Human breast cancer cells in vitro exhibit increased levels of progestin receptors (PgR) after brief exposure to physiologic concentrations of estrogens. Prior clinical studies have positively correlated the responsiveness of metastatic breast cancer to progestin therapy with the le

4003 ICE Study: A prospective, multi-cen

4003 ICE Study: A prospective, multi-centre, controlled, open-label, randomized phase III trial of ibandronate (I) with or without capecitabine (X) in elderly patients (pts) with early breast cancer (GBG 32)

✍ T. Reimer; U. Nitz; J. Potenberg; B. Conrad; H. Graf; M. Just; H. Eidtmann; S. L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB